2831 Highway 15
Fairbury, NE
Nebraska COVID-19 Cases
Nebraska New Coronavirus Cases:
Nebraska Total Coronavirus Cases: 574,399
Nebraska New Coronavirus Deaths:
Nebraska Total Coronavirus Deaths: 5,063
Nebraska Total Coronavirus Cases: 574,399
Nebraska New Coronavirus Deaths:
Nebraska Total Coronavirus Deaths: 5,063
U.S. New Coronavirus Cases: 1,648
U.S. Total Coronavirus Cases: 107,184,620
U.S. New Coronavirus Deaths: 8
U.S. Total Coronavirus Deaths: 1,166,662
U.S. Total Coronavirus Cases: 107,184,620
U.S. New Coronavirus Deaths: 8
U.S. Total Coronavirus Deaths: 1,166,662
Last updated June 10, 2023
Gilead and other towns across Nebraska are putting proactive measures in place to quell the spread of COVID-19. Disruptions to school, work, and major public gatherings are already manifesting and it’s important to stay up to date on what’s happening in the Gilead, NE community.
Stay up to date and informed with our resources: Breaking public health news, information on your local Nebraska hospitals and healthcare facilities, information from the Nebraska Public Health Department, and Twitter updates from Nebraska government officials. Continue to visit our website for the latest updates.
Coronavirus News for Gilead
Gilead recalls one lot of COVID-19 drug Veklury due to presence of glass particle in vial
Gilead Sciences has issued a voluntary recall of one lot of COVID-19 antiviral Veklury, also known as remdesivir, after confirming "the presence of a glass particle" in a vial. A customer complaint ... More info »
FiercePharma - 09/24/2024 08:57pmGilead Rises As Drug Shows Effectiveness To Combat Coronavirus
GILD is rising on its potential to treat the coronavirus. The potential upside from such a treatment is hard to ignore. GILD reports quarterly earnings after hours. Revenue and earnings growth could ... More info »
Seeking Alpha - 02/04/2020 08:23amGilead Sciences Stock Falls as Slumping COVID-19, Cancer Drug Sales Hit Revenue
Gilead Sciences missed first-quarter revenue estimates as sales of its COVID-19 and cancer drugs declined. The biopharma's profit got a lift from higher prices and demand for its HIV treatments. More info »
MSN - 04/25/2025 02:50am
